{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:20Z","timestamp":1790835620585,"version":"4.1.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2020,4,15]]},"DOI":"10.1038\/s41584-020-0386-4","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T10:02:48Z","timestamp":1582624968000},"page":"208-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":194,"title":["Raynaud phenomenon and digital ulcers in systemic sclerosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-4909","authenticated-orcid":false,"given":"Michael","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2364","authenticated-orcid":false,"given":"John D.","family":"Pauling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"386_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto, T. R. & Whitfield, M. L. The pathogenesis of systemic sclerosis. Annu. Rev. Pathol. 6, 509\u2013537 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"386_CR2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. K. Systemic sclerosis. Lancet 390, 1685\u20131699 (2017).","journal-title":"Lancet"},{"key":"386_CR3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","volume":"71","author":"FMP Meier","year":"2012","unstructured":"Meier, F. M. P. et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann. Rheum. Dis. 71, 1355\u20131360 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR4","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","volume":"46","author":"PA Merkel","year":"2002","unstructured":"Merkel, P. A. et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon. Arthritis Rheum. 46, 2410\u20132420 (2002).","journal-title":"Arthritis Rheum."},{"key":"386_CR5","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202\u2013205 (1988).","journal-title":"J. Rheumatol."},{"key":"386_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","volume":"56","author":"M Hughes","year":"2017","unstructured":"Hughes, M. & Herrick, A. L. Digital ulcers in systemic sclerosis. Rheumatology 56, 14\u201325 (2017).","journal-title":"Rheumatology"},{"key":"386_CR7","first-page":"2423","volume":"34","author":"E Hachulla","year":"2007","unstructured":"Hachulla, E. et al. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J. Rheumatol. 34, 2423\u20132430 (2007).","journal-title":"J. Rheumatol."},{"issue":"Suppl. 3","key":"386_CR8","first-page":"iii19","volume":"48","author":"V Steen","year":"2009","unstructured":"Steen, V., Denton, C. P., Pope, J. E. & Matucci-Cerinic, M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology 48 (Suppl. 3), iii19\u2013iii24 (2009).","journal-title":"Rheumatology"},{"key":"386_CR9","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3899\/jrheum.081044","volume":"36","author":"KP Tiev","year":"2009","unstructured":"Tiev, K. P. et al. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (Itin\u00e9rAIR-Scl\u00e9rodermie). J. Rheumatol. 36, 1470\u20131476 (2009).","journal-title":"J. Rheumatol."},{"key":"386_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/acr.20336","volume":"63","author":"S Khimdas","year":"2011","unstructured":"Khimdas, S. et al. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Arthritis Care Res. 63, 142\u2013149 (2011).","journal-title":"Arthritis Care Res."},{"key":"386_CR11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/03009742.2013.780095","volume":"42","author":"H Ennis","year":"2013","unstructured":"Ennis, H. et al. A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact. Scand. J. Rheumatol. 42, 483\u2013486 (2013).","journal-title":"Scand. J. Rheumatol."},{"key":"386_CR12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/annrheumdis-2015-207271","volume":"75","author":"EG Wirz","year":"2015","unstructured":"Wirz, E. G. et al. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann. Rheum. Dis. 75, 1285\u20131292 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/157339710904140417125627","volume":"9","author":"S Lambova","year":"2013","unstructured":"Lambova, S., Batalov, A., Sapundzhiev, L. & M\u00fcller-Ladner, U. Digital ulcers in systemic sclerosis - frequency, subtype distribution and clinical outcome. Curr. Rheumatol. Rev. 9, 268\u2013273 (2013).","journal-title":"Curr. Rheumatol. Rev."},{"key":"386_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10067-009-1155-6","volume":"28","author":"P Caramaschi","year":"2009","unstructured":"Caramaschi, P. et al. A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost. Clin. Rheumatol. 28, 807\u2013813 (2009).","journal-title":"Clin. Rheumatol."},{"key":"386_CR15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","volume":"49","author":"L Amanzi","year":"2010","unstructured":"Amanzi, L. et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology 49, 1374\u20131382 (2010).","journal-title":"Rheumatology"},{"key":"386_CR16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","volume":"75","author":"M Matucci-Cerinic","year":"2016","unstructured":"Matucci-Cerinic, M. et al. Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO registry. Ann. Rheum. Dis. 75, 1770\u20131776 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR17","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s10067-019-04745-5","volume":"38","author":"JD Pauling","year":"2019","unstructured":"Pauling, J. D., Hughes, M. & Pope, J. E. Raynaud\u2019s phenomenon - an update on diagnosis, classification and management. Clin. Rheumatol. 38, 3317\u20133330 (2019).","journal-title":"Clin. Rheumatol."},{"key":"386_CR18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/acr.23729","volume":"71","author":"JD Pauling","year":"2019","unstructured":"Pauling, J. D., Reilly, E., Smith, T. & Frech, T. M. Evolving symptoms of Raynaud\u2019s phenomenon in systemic sclerosis are associated with physician and patient-reported assessments of disease severity. Arthritis Care Res. 71, 1119\u20131126 (2019).","journal-title":"Arthritis Care Res."},{"key":"386_CR19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.180818","volume":"46","author":"JD Pauling","year":"2019","unstructured":"Pauling, J. D., Reilly, E., Smith, T. & Frech, T. M. Factors influencing Raynaud\u2019s condition score diary outcomes in systemic sclerosis. J. Rheumatol. 46, 1326\u20131334 (2019).","journal-title":"J. Rheumatol."},{"key":"386_CR20","first-page":"485","volume":"10","author":"EC LeRoy","year":"1992","unstructured":"LeRoy, E. C. & Medsger, T. A. Raynaud\u2019s phenomenon: a proposal for classification. Clin. Exp. Rheumatol. 10, 485\u2013488 (1992).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rheumatology\/32.5.357","volume":"32","author":"P Brennan","year":"1993","unstructured":"Brennan, P. et al. Validity and reliability of three methods used in the diagnosis of Raynaud\u2019s phenomenon. The UK Scleroderma Study Group. Br. J. Rheumatol. 32, 357\u2013361 (1993).","journal-title":"Br. J. Rheumatol."},{"key":"386_CR22","first-page":"454","volume":"15","author":"HR Maricq","year":"1988","unstructured":"Maricq, H. R. & Weinrich, M. C. Diagnosis of Raynaud\u2019s phenomenon assisted by color charts. J. Rheumatol. 15, 454\u2013459 (1988).","journal-title":"J. Rheumatol."},{"key":"386_CR23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMcp013013","volume":"347","author":"FM Wigley","year":"2002","unstructured":"Wigley, F. M. Raynaud\u2019s phenomenon. N. Engl. J. Med. 347, 1001\u20131008 (2002).","journal-title":"N. Engl. J. Med."},{"key":"386_CR24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","volume":"48\u201349","author":"E Maverakis","year":"2014","unstructured":"Maverakis, E. et al. International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon. J. Autoimmun. 48\u201349, 60\u201365 (2014).","journal-title":"J. Autoimmun."},{"key":"386_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.2007.072686","volume":"67","author":"SI Nihtyanova","year":"2008","unstructured":"Nihtyanova, S. I., Brough, G. M., Black, C. M. & Denton, C. P. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann. Rheum. Dis. 67, 120\u2013123 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez558","author":"C Mihai","year":"2019","unstructured":"Mihai, C. et al. Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/kez558 (2019).","journal-title":"Rheumatology"},{"key":"386_CR27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3899\/jrheum.130900","volume":"41","author":"L Mouthon","year":"2014","unstructured":"Mouthon, L. et al. Ischemic digital ulcers affect hand disability and pain in systemic sclerosis. J. Rheumatol. 41, 1317\u20131323 (2014).","journal-title":"J. Rheumatol."},{"key":"386_CR28","first-page":"71","volume":"31","author":"L Guillevin","year":"2013","unstructured":"Guillevin, L. et al. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO registry. Clin. Exp. Rheumatol. 31, 71\u201380 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.2008.094193","volume":"69","author":"L Mouthon","year":"2010","unstructured":"Mouthon, L. et al. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann. Rheum. Dis. 69, 214\u2013217 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/acr.20342","volume":"63","author":"A B\u00e9rezn\u00e9","year":"2011","unstructured":"B\u00e9rezn\u00e9, A. et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res. 63, 277\u2013285 (2011).","journal-title":"Arthritis Care Res."},{"key":"386_CR31","first-page":"S47","volume":"33","author":"M Brand","year":"2015","unstructured":"Brand, M. et al. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin. Exp. Rheumatol. 33, S47\u2013S54 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jbspin.2009.05.015","volume":"77","author":"F Cozzi","year":"2010","unstructured":"Cozzi, F. et al. The social costs of digital ulcer management in sclerodema patients: an observational Italian pilot study. Joint Bone Spine 77, 83\u201384 (2010).","journal-title":"Joint Bone Spine"},{"key":"386_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","volume":"64","author":"D Giuggioli","year":"2012","unstructured":"Giuggioli, D., Manfredi, A., Colaci, M., Lumetti, F. & Ferri, C. Scleroderma digital ulcers complicated by infection with fecal pathogens. Arthritis Care Res. 64, 295\u2013297 (2012).","journal-title":"Arthritis Care Res."},{"key":"386_CR34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10067-012-2161-7","volume":"32","author":"D Giuggioli","year":"2013","unstructured":"Giuggioli, D., Manfredi, A., Colaci, M., Lumetti, F. & Ferri, C. Osteomyelitis complicating scleroderma digital ulcers. Clin. Rheumatol. 32, 623\u2013627 (2013).","journal-title":"Clin. Rheumatol."},{"key":"386_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10067-019-04662-7","volume":"39","author":"S Barsotti","year":"2020","unstructured":"Barsotti, S. et al. Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis? Clin. Rheumatol. 39, 69\u201375 (2020).","journal-title":"Clin. Rheumatol."},{"key":"386_CR36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2012.96","volume":"8","author":"AL Herrick","year":"2012","unstructured":"Herrick, A. L. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat. Rev. Rheumatol. 8, 469\u2013479 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"386_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mehy.2018.04.024","volume":"116","author":"M Hughes","year":"2018","unstructured":"Hughes, M., Murray, A., Denton, C. P. & Herrick, A. L. Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy? Med. Hypotheses 116, 101\u2013104 (2018).","journal-title":"Med. Hypotheses"},{"key":"386_CR38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.24394","volume":"61","author":"M Sebastiani","year":"2009","unstructured":"Sebastiani, M. et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum. 61, 688\u2013694 (2009).","journal-title":"Arthritis Rheum."},{"key":"386_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/annrheumdis-2011-200022","volume":"71","author":"M Sebastiani","year":"2012","unstructured":"Sebastiani, M. et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann. Rheum. Dis. 71, 67\u201370 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR40","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","volume":"71","author":"V Smith","year":"2012","unstructured":"Smith, V. et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann. Rheum. Dis. 71, 1636\u20131639 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.semarthrit.2018.02.005","volume":"48","author":"D Paxton","year":"2018","unstructured":"Paxton, D. & Pauling, J. D. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review. Semin. Arthritis Rheum. 48, 482\u2013494 (2018).","journal-title":"Semin. Arthritis Rheum."},{"key":"386_CR42","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/40.10.1102","volume":"40","author":"MC Wan","year":"2001","unstructured":"Wan, M. C., Moore, T., Hollis, S. & Herrick, A. L. Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology 40, 1102\u20131105 (2001).","journal-title":"Rheumatology"},{"key":"386_CR43","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/rheumatology\/keu227","volume":"53","author":"S Wig","year":"2014","unstructured":"Wig, S. et al. A longitudinal study of ankle brachial pressure indices in a cohort of patients with systemic sclerosis. Rheumatology 53, 2009\u20132013 (2014).","journal-title":"Rheumatology"},{"key":"386_CR44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3899\/jrheum.100767","volume":"38","author":"M Manetti","year":"2011","unstructured":"Manetti, M. et al. Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis. J. Rheumatol. 38, 297\u2013301 (2011).","journal-title":"J. Rheumatol."},{"key":"386_CR45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3899\/jrheum.150035","volume":"43","author":"J Blagojevic","year":"2016","unstructured":"Blagojevic, J. et al. Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: a challenge for the rheumatologist. J. Rheumatol. 43, 592\u2013598 (2016).","journal-title":"J. Rheumatol."},{"key":"386_CR46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac, J. et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann. Rheum. Dis. 70, 476\u2013481 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR47","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig, M. et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 58, 3902\u20133912 (2008).","journal-title":"Arthritis Rheum."},{"key":"386_CR48","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","volume":"54","author":"M Hughes","year":"2015","unstructured":"Hughes, M. et al. Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Rheumatology 54, 2015\u20132024 (2015).","journal-title":"Rheumatology"},{"key":"386_CR49","doi-asserted-by":"crossref","unstructured":"Flower, V., Pauling, J. D. & McHugh, N. in Raynaud\u2019s Phenomenon: A Guide to Pathogenesis and Treatment (eds. Wigley, F. M., Herrick, A. L. & Flavahan, N. A.) 253\u2013266 (Springer, 2015).","DOI":"10.1007\/978-1-4939-1526-2_15"},{"key":"386_CR50","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/rheumatology\/kex458","volume":"57","author":"JD Pauling","year":"2017","unstructured":"Pauling, J. D. et al. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1\/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis. Rheumatology 57, 712\u2013717 (2017).","journal-title":"Rheumatology"},{"key":"386_CR51","first-page":"80","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho, K. T. & Reveille, J. D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res. Ther. 5, 80 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"386_CR52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.59.1.39","volume":"59","author":"M Ho","year":"2000","unstructured":"Ho, M., Veale, D., Eastmond, C., Nuki, G. & Belch, J. Macrovascular disease and systemic sclerosis. Ann. Rheum. Dis. 59, 39\u201343 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR53","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.30380","volume":"63","author":"K Au","year":"2011","unstructured":"Au, K. et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum. 63, 2078\u20132090 (2011).","journal-title":"Arthritis Rheum."},{"key":"386_CR54","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00296-009-0906-7","volume":"29","author":"JH Park","year":"2009","unstructured":"Park, J. H. et al. Ulnar artery vasculopathy in systemic sclerosis. Rheumatol. Int. 29, 1081\u20131086 (2009).","journal-title":"Rheumatol. Int."},{"key":"386_CR55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/rheumatology\/ker414","volume":"51","author":"M Frerix","year":"2012","unstructured":"Frerix, M., Stegbauer, J., Dragun, D., Kreuter, A. & Weiner, S. M. Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. Rheumatology 51, 735\u2013742 (2012).","journal-title":"Rheumatology"},{"key":"386_CR56","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 72, 1747\u20131755 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR57","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","volume":"68","author":"M Cutolo","year":"2016","unstructured":"Cutolo, M. et al. Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study. Arthritis Rheumatol. 68, 2527\u20132539 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"386_CR58","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s10067-006-0489-6","volume":"26","author":"M Baron","year":"2007","unstructured":"Baron, M. et al. Office capillaroscopy in systemic sclerosis. Clin. Rheumatol. 26, 1268\u20131274 (2007).","journal-title":"Clin. Rheumatol."},{"key":"386_CR59","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/rheumatology\/keu533","volume":"54","author":"M Hughes","year":"2015","unstructured":"Hughes, M. et al. A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis-spectrum disorders. Rheumatology 54, 1435\u20131442 (2015).","journal-title":"Rheumatology"},{"key":"386_CR60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mvr.2018.03.004","volume":"118","author":"C Mihai","year":"2018","unstructured":"Mihai, C. et al. The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis. Microvasc. Res. 118, 113\u2013120 (2018).","journal-title":"Microvasc. Res."},{"key":"386_CR61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00296-019-04427-0","volume":"40","author":"V Bernadino","year":"2020","unstructured":"Bernadino, V., Rodrigues, A., Llad\u00f3, A. & Panarra, A. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic. Rheumatol. Int. 40, 295\u2013301 (2020).","journal-title":"Rheumatol. Int."},{"key":"386_CR62","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C. & Accardo, S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J. Rheumatol. 27, 155\u2013160 (2000).","journal-title":"J. Rheumatol."},{"key":"386_CR63","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","volume":"18","author":"V Smith","year":"2019","unstructured":"Smith, V. et al. Fast track algorithm: how to differentiate a \u201cscleroderma pattern\u201d from a \u201cnon-scleroderma pattern\u201d. Autoimmun. Rev. 18, 102394 (2019).","journal-title":"Autoimmun. Rev."},{"key":"386_CR64","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3899\/jrheum.091356","volume":"37","author":"M Cutolo","year":"2010","unstructured":"Cutolo, M. et al. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. J. Rheumatol. 37, 1174\u20131180 (2010).","journal-title":"J. Rheumatol."},{"key":"386_CR65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mvr.2016.02.007","volume":"105","author":"B Ruaro","year":"2016","unstructured":"Ruaro, B. et al. Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients. Microvasc. Res. 105, 119\u2013124 (2016).","journal-title":"Microvasc. Res."},{"key":"386_CR66","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3899\/jrheum.141437","volume":"42","author":"JD Pauling","year":"2015","unstructured":"Pauling, J. D., Shipley, J. A., Hart, D. J., McGrogan, A. & McHugh, N. J. Use of laser speckle contrast imaging to assess digital microvascular function in primary Raynaud phenomenon and systemic sclerosis: a comparison using the Raynaud Condition Score Diary. J. Rheumatol. 42, 1163\u20131168 (2015).","journal-title":"J. Rheumatol."},{"key":"386_CR67","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/rheumatology\/keh244","volume":"43","author":"ME Anderson","year":"2004","unstructured":"Anderson, M. E., Moore, T. L., Lunt, M. & Herrick, A. L. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging\u2013a non-invasive technique by which to measure microvascular dysfunction in Raynaud\u2019s phenomenon. Rheumatology 43, 986\u2013991 (2004).","journal-title":"Rheumatology"},{"key":"386_CR68","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/rheumatology\/kem085","volume":"46","author":"H Gunawardena","year":"2007","unstructured":"Gunawardena, H., Harris, N. D., Carmichael, C. & McHugh, N. J. Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology 46, 1079\u20131082 (2007).","journal-title":"Rheumatology"},{"key":"386_CR69","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/rheumatology\/ket421","volume":"53","author":"AL Herrick","year":"2014","unstructured":"Herrick, A. L. et al. A double-blind, randomized, placebo-controlled crossover trial of the \u03b12C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis. Rheumatology 53, 948\u2013952 (2014).","journal-title":"Rheumatology"},{"key":"386_CR70","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1136\/annrheumdis-2012-201536","volume":"72","author":"LK Hummers","year":"2013","unstructured":"Hummers, L. K. et al. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Ann. Rheum. Dis. 72, 1962\u20131967 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR71","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.autrev.2018.01.023","volume":"17","author":"M Cutolo","year":"2018","unstructured":"Cutolo, M. et al. Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. Autoimmun. Rev. 17, 775\u2013780 (2018).","journal-title":"Autoimmun. Rev."},{"key":"386_CR72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.40457","volume":"70","author":"JD Wilkinson","year":"2018","unstructured":"Wilkinson, J. D. et al. A multicenter study of the validity and reliability of responses to hand cold challenge as measured by laser speckle contrast imaging and thermography: outcome measures for systemic sclerosis-related Raynaud\u2019s phenomenon. Arthritis Rheumatol. 70, 903\u2013911 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"386_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.08.007","author":"K Melsens","year":"2019","unstructured":"Melsens, K. et al. The preliminary validation of laser Doppler flowmetry in systemic sclerosis in accordance with the OMERACT filter: a systematic review. Semin. Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.08.007 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"386_CR74","first-page":"127","volume":"2","author":"G Dinsdale","year":"2014","unstructured":"Dinsdale, G. & Herrick, A. L. Vascular diagnostics for Raynaud\u2019s phenomenon. J. Vasc. Diagn. 2, 127\u2013139 (2014).","journal-title":"J. Vasc. Diagn."},{"key":"386_CR75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.mvr.2011.03.007","volume":"82","author":"JD Pauling","year":"2011","unstructured":"Pauling, J. D., Flower, V., Shipley, J. A., Harris, N. D. & McHugh, N. J. Influence of the cold challenge on the discriminatory capacity of the digital distal-dorsal difference in the thermographic assessment of Raynaud\u2019s phenomenon. Microvasc. Res. 82, 364\u2013368 (2011).","journal-title":"Microvasc. Res."},{"key":"386_CR76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/rheumatology\/kel330","volume":"46","author":"ME Anderson","year":"2007","unstructured":"Anderson, M. E., Moore, T. L., Lunt, M. & Herrick, A. L. The \u2018distal-dorsal difference\u2019: a thermographic parameter by which to differentiate between primary and secondary Raynaud\u2019s phenomenon. Rheumatology 46, 533\u2013538 (2007).","journal-title":"Rheumatology"},{"key":"386_CR77","doi-asserted-by":"crossref","unstructured":"Pauling, J. & Murray, A. in Raynaud\u2019s Phenomenon: A Guide to Pathogenesis and Treatment (eds. Wigley, F. M., Herrick, A. L. & Flavahan, N. A.) 199\u2013242 (Springer, 2015).","DOI":"10.1007\/978-1-4939-1526-2_13"},{"key":"386_CR78","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/rheumatology\/kex045","volume":"56","author":"S L\u00fcders","year":"2017","unstructured":"L\u00fcders, S. et al. Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers. Rheumatology 56, 1865\u20131873 (2017).","journal-title":"Rheumatology"},{"key":"386_CR79","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/acr.22965","volume":"69","author":"A Lescoat","year":"2017","unstructured":"Lescoat, A. et al. Vascular evaluation of the hand by power doppler ultrasonography and new predictive markers of ischemic digital ulcers in systemic sclerosis: results of a prospective pilot study. Arthritis Care Res. 69, 543\u2013551 (2017).","journal-title":"Arthritis Care Res."},{"key":"386_CR80","doi-asserted-by":"crossref","unstructured":"Allanore, Y., Drappe, J.-L. & Reifsnyder, T. in Raynaud\u2019s Phenomenon: A Guide to Pathogenesis and Treatment (eds. Wigley, F. M., Herrick, A. L. & Flavahan, N. A.) 243\u2013252 (Springer, 2015).","DOI":"10.1007\/978-1-4939-1526-2_14"},{"key":"386_CR81","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3899\/jrheum.171486","volume":"46","author":"C Bruni","year":"2019","unstructured":"Bruni, C. et al. Preliminary validation of the digital ulcer clinical assessment score in systemic sclerosis. J. Rheumatol. 46, 603\u2013608 (2019).","journal-title":"J. Rheumatol."},{"key":"386_CR82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-019-1822-1","volume":"21","author":"J Blagojevic","year":"2019","unstructured":"Blagojevic, J. et al. Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher\/European Scleroderma Trials and Research group (EUSTAR) survey. Arthritis Res. Ther. 21, 35 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"386_CR83","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2017-212829","volume":"77","author":"G Dinsdale","year":"2018","unstructured":"Dinsdale, G. et al. Tracking digital ulcers in systemic sclerosis: a feasibility study assessing lesion area in patient-recorded smartphone photographs. Ann. Rheum. Dis. 77, 1382\u20131384 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR84","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acr.23300","volume":"70","author":"V Simpson","year":"2018","unstructured":"Simpson, V., Hughes, M., Wilkinson, J., Herrick, A. L. & Dinsdale, G. Quantifying digital ulcers in systemic sclerosis: reliability of digital planimetry in measuring lesion size. Arthritis Care Res. 70, 486\u2013490 (2018).","journal-title":"Arthritis Care Res."},{"key":"386_CR85","first-page":"218","volume":"35","author":"M Hughes","year":"2017","unstructured":"Hughes, M. et al. A pilot study using high-frequency ultrasound to measure digital ulcers: a possible outcome measure in systemic sclerosis clinical trials? Clin. Exp. Rheumatol. 35, 218\u2013219 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR86","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s10067-018-3986-5","volume":"37","author":"YA Suliman","year":"2018","unstructured":"Suliman, Y. A. et al. Ultrasound characterization of cutaneous ulcers in systemic sclerosis. Clin. Rheumatol. 37, 1555\u20131561 (2018).","journal-title":"Clin. Rheumatol."},{"key":"386_CR87","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s10067-018-4099-x","volume":"37","author":"M Hughes","year":"2018","unstructured":"Hughes, M. Response to \u2018Ultrasound characterization of cutaneous ulcers in systemic sclerosis\u2019. Clin. Rheumatol. 37, 2013 (2018).","journal-title":"Clin. Rheumatol."},{"key":"386_CR88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5301\/jsrd.5000238","volume":"2","author":"W Li","year":"2017","unstructured":"Li, W. & Frech, T. M. The critical need for accurately defining digital ulcers in scleroderma. J. Scleroderma Relat. Disord. 2, 69\u201371 (2017).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR89","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.24333","volume":"60","author":"AL Herrick","year":"2009","unstructured":"Herrick, A. L. et al. Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis Rheum. 60, 878\u2013882 (2009).","journal-title":"Arthritis Rheum."},{"key":"386_CR90","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/acr.22833","volume":"68","author":"M Hughes","year":"2016","unstructured":"Hughes, M. et al. Does the clinical context improve the reliability of rheumatologists grading digital ulcers in systemic sclerosis? Arthritis Care Res. 68, 1340\u20131345 (2016).","journal-title":"Arthritis Care Res."},{"key":"386_CR91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/2397198318764796","volume":"3","author":"M Hughes","year":"2018","unstructured":"Hughes, M. et al. Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: a challenge for clinical trial design. J. Scleroderma Relat. Disord. 3, 170\u2013174 (2018).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","volume":"70","author":"M Matucci-Cerinic","year":"2011","unstructured":"Matucci-Cerinic, M. et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 70, 32\u201338 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR93","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1002\/art.22965","volume":"56","author":"AE Gliddon","year":"2007","unstructured":"Gliddon, A. E. et al. Prevention of vascular damage in scleroderma and autoimmune Raynaud\u2019s phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis Rheum. 56, 3837\u20133846 (2007).","journal-title":"Arthritis Rheum."},{"key":"386_CR94","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","volume":"75","author":"E Hachulla","year":"2016","unstructured":"Hachulla, E. et al. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study. Ann. Rheum. Dis. 75, 1009\u20131015 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR95","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2016.5258","volume":"315","author":"D Khanna","year":"2016","unstructured":"Khanna, D. et al. Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials. JAMA 315, 1975\u20131988 (2016).","journal-title":"JAMA"},{"key":"386_CR96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5301\/jsrd.5000232","volume":"2","author":"JR Seibold","year":"2017","unstructured":"Seibold, J. R. et al. Digital ulcers in SSc treated with oral treprostinil: a randomized, double-blind, placebo-controlled study with open-label follow-up. J. Scleroderma Relat. Disord. 2, 42\u201349 (2017).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5301\/jsrd.5000236","volume":"2","author":"YA Suliman","year":"2017","unstructured":"Suliman, Y. A. et al. Defining skin ulcers in systemic sclerosis: systematic literature review and proposed World Scleroderma Foundation (WSF) definition. J. Scleroderma Relat. Disord. 2, 115\u2013120 (2017).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR98","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/art.10685","volume":"46","author":"BJ Harrison","year":"2002","unstructured":"Harrison, B. J., Silman, A. J., Hider, S. L. & Herrick, A. L. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum. 46, 3312\u20133316 (2002).","journal-title":"Arthritis Rheum."},{"key":"386_CR99","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.40557","volume":"70","author":"VK Jaeger","year":"2018","unstructured":"Jaeger, V. K. et al. Brief report: smoking in systemic sclerosis: a longitudinal European Scleroderma Trials and Research group study. Arthritis Rheumatol. 70, 1829\u20131834 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"386_CR100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semarthrit.2016.05.001","volume":"46","author":"CA Sharp","year":"2016","unstructured":"Sharp, C. A., Akram, Q., Hughes, M., Muir, L. & Herrick, A. L. Differential diagnosis of critical digital ischemia in systemic sclerosis: report of five cases and review of the literature. Semin. Arthritis Rheum. 46, 209\u2013216 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"386_CR101","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/annrheumdis-2016-209481","volume":"75","author":"Y Allanore","year":"2016","unstructured":"Allanore, Y. et al. Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort. Ann. Rheum. Dis. 75, 1736\u20131740 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR102","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/acr.23522","volume":"70","author":"SL Murphy","year":"2018","unstructured":"Murphy, S. L. et al. Occupational therapy treatment to improve upper extremity function in individuals with early systemic sclerosis: a pilot study. Arthritis Care Res. 70, 1653\u20131660 (2018).","journal-title":"Arthritis Care Res."},{"key":"386_CR103","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3899\/jrheum.181130","volume":"46","author":"K Becetti","year":"2019","unstructured":"Becetti, K. et al. Physical or occupational therapy use in systemic sclerosis: a scleroderma patient-centered intervention network cohort study. J. Rheumatol. 46, 1605\u20131613 (2019).","journal-title":"J. Rheumatol."},{"key":"386_CR104","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5301\/jsrd.5000268","volume":"3","author":"N Lebedoff","year":"2017","unstructured":"Lebedoff, N. et al. Review of local wound management for scleroderma-associated digital ulcers. J. Scleroderma Relat. Disord. 3, 66\u201370 (2017).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04924-4","author":"M Hughes","year":"2020","unstructured":"Hughes, M. et al. Digital ulcer debridement in systemic sclerosis: a systematic literature review. Clin. Rheumatol. https:\/\/doi.org\/10.1007\/s10067-019-04924-4 (2020).","journal-title":"Clin. Rheumatol."},{"key":"386_CR106","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10067-005-0016-1","volume":"25","author":"S Ozgocmen","year":"2006","unstructured":"Ozgocmen, S., Kaya, A. & Coskun, B. K. Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma). Clin. Rheumatol. 25, 378\u2013379 (2006).","journal-title":"Clin. Rheumatol."},{"key":"386_CR107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10067-013-2460-7","volume":"33","author":"M Baron","year":"2014","unstructured":"Baron, M., Chung, L., Gyger, G., Hummers, L. & Khanna, D. Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis. Clin. Rheumatol. 33, 207\u2013214 (2014).","journal-title":"Clin. Rheumatol."},{"key":"386_CR108","first-page":"1694","volume":"33","author":"YM Markus","year":"2006","unstructured":"Markus, Y. M., Bell, M. J. & Evans, A. W. Ischemic scleroderma wounds successfully treated with hyperbaric oxygen therapy. J. Rheumatol. 33, 1694\u20131696 (2006).","journal-title":"J. Rheumatol."},{"key":"386_CR109","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ijd.13570","volume":"56","author":"B Mirasoglu","year":"2017","unstructured":"Mirasoglu, B., Bagli, B. S. & Aktas, S. Hyperbaric oxygen therapy for chronic ulcers in systemic sclerosis \u2013 case series. Int. J. Dermatol. 56, 636\u2013640 (2017).","journal-title":"Int. J. Dermatol."},{"key":"386_CR110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.1780271009","volume":"27","author":"VL Beckett","year":"1984","unstructured":"Beckett, V. L. et al. Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum. 27, 1137\u20131143 (1984).","journal-title":"Arthritis Rheum."},{"key":"386_CR111","first-page":"499","volume":"18","author":"CP Denton","year":"2000","unstructured":"Denton, C. P., Howell, K., Stratton, R. J. & Black, C. M. Long-term low molecular weight heparin therapy for severe Raynaud\u2019s phenomenon: a pilot study. Clin. Exp. Rheumatol. 18, 499\u2013502 (2000).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR112","first-page":"1801","volume":"35","author":"A Abou-Raya","year":"2008","unstructured":"Abou-Raya, A., Abou-Raya, S. & Helmii, M. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud\u2019s phenomenon and digital ulcers. J. Rheumatol. 35, 1801\u20131808 (2008).","journal-title":"J. Rheumatol."},{"key":"386_CR113","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10067-009-1251-7","volume":"28","author":"E Rosato","year":"2009","unstructured":"Rosato, E., Borghese, F., Pisarri, S. & Salsano, F. The treatment with N-acetylcysteine of Raynaud\u2019s phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients. Clin. Rheumatol. 28, 1379\u20131384 (2009).","journal-title":"Clin. Rheumatol."},{"key":"386_CR114","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.semarthrit.2015.10.013","volume":"45","author":"K Ladak","year":"2016","unstructured":"Ladak, K. & Pope, J. E. A review of the effects of statins in systemic sclerosis. Semin. Arthritis Rheum. 45, 698\u2013705 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"386_CR115","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez522","author":"M Hughes","year":"2019","unstructured":"Hughes, M., Khanna, D. & Pauling, J. D. Drug initiation and escalation strategies of vasodilator therapies for Raynaud\u2019s phenomenon: can we treat to target? Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/kez522 (2019).","journal-title":"Rheumatology"},{"key":"386_CR116","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acr.22018","volume":"65","author":"T Tingey","year":"2013","unstructured":"Tingey, T., Shu, J., Smuczek, J. & Pope, J. Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis. Arthritis Care Res. 65, 1460\u20131471 (2013).","journal-title":"Arthritis Care Res."},{"key":"386_CR117","unstructured":"Hughes, M. & Herrick, A. in Novel Insights into Systemic Sclerosis Management. (eds M. Cutolo & V. Smith) 232\u2013241 (Future Medicine, 2013)."},{"key":"386_CR118","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn, J. H. et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 50, 3985\u20133993 (2004).","journal-title":"Arthritis Rheum."},{"key":"386_CR119","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40674-019-00118-w","volume":"5","author":"JD Pauling","year":"2019","unstructured":"Pauling, J. D., Nagaraja, V. & Khanna, D. Insight into the contrasting findings of therapeutic trials of digital ischaemic manifestations of systemic sclerosis. Curr. Treat. Options Rheumatol. 5, 85\u2013103 (2019).","journal-title":"Curr. Treat. Options Rheumatol."},{"key":"386_CR120","first-page":"1407","volume":"19","author":"FM Wigley","year":"1992","unstructured":"Wigley, F. M., Seibold, J. R., Wise, R. A., McCloskey, D. A. & Dole, W. P. Intravenous iloprost treatment of Raynaud\u2019s phenomenon and ischemic ulcers secondary to systemic sclerosis. J. Rheumatol. 19, 1407\u20131414 (1992).","journal-title":"J. Rheumatol."},{"key":"386_CR121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","volume":"120","author":"FM Wigley","year":"1994","unstructured":"Wigley, F. M. et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann. Intern. Med. 120, 199\u2013206 (1994).","journal-title":"Ann. Intern. Med."},{"key":"386_CR122","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","volume":"132","author":"DB Badesch","year":"2000","unstructured":"Badesch, D. B. et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann. Intern. Med. 132, 425\u2013434 (2000).","journal-title":"Ann. Intern. Med."},{"key":"386_CR123","first-page":"888","volume":"7","author":"A Ambach","year":"2009","unstructured":"Ambach, A., Seo, W., Bonnekoh, B. & Gollnick, H. Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil. J. Dtsch. Dermatol. Ges. 7, 888\u2013891 (2009).","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"386_CR124","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.jaad.2011.04.029","volume":"65","author":"P Moinzadeh","year":"2011","unstructured":"Moinzadeh, P., Hunzelmann, N. & Krieg, T. Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis. J. Am. Acad. Dermatol. 65, e102\u2013e104 (2011).","journal-title":"J. Am. Acad. Dermatol."},{"key":"386_CR125","doi-asserted-by":"crossref","unstructured":"Muir, L. in Raynaud\u2019s Phenomenon: A Guide to Pathogenesis and Treatment (eds. Wigley, F. M., Herrick, A. L. & Flavahan, N. A.) 361\u2013372 (Springer, 2015).","DOI":"10.1007\/978-1-4939-1526-2_22"},{"key":"386_CR126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/micr.22379","volume":"35","author":"A Momeni","year":"2015","unstructured":"Momeni, A. et al. Surgical treatment of systemic sclerosis \u2014 is it justified to offer peripheral sympathectomy earlier in the disease process? Microsurgery 35, 441\u2013446 (2015).","journal-title":"Microsurgery"},{"key":"386_CR127","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/SAP.0000000000000614","volume":"75","author":"G Chiou","year":"2015","unstructured":"Chiou, G. et al. Digital sympathectomy in patients with scleroderma: an overview of the practice and referral patterns and perceptions of rheumatologists. Ann. Plast. Surg. 75, 637\u2013643 (2015).","journal-title":"Ann. Plast. Surg."},{"key":"386_CR128","doi-asserted-by":"crossref","first-page":"990.e1","DOI":"10.1016\/j.jhsa.2019.01.004","volume":"44","author":"J Leyden","year":"2019","unstructured":"Leyden, J. et al. Upper extremity angiographic patterns in systemic sclerosis: implications for surgical treatment. J. Hand Surg. Am. 44, 990.e1\u2013990.e7 (2019).","journal-title":"J. Hand Surg. Am."},{"key":"386_CR129","doi-asserted-by":"publisher","DOI":"10.1177\/2397198319863565","author":"ES Satteson","year":"2019","unstructured":"Satteson, E. S., Chung, M. P., Chung, L. S. & Chang, J. Microvascular hand surgery for digital ischemia in scleroderma. J. Scleroderma Relat. Disord. https:\/\/doi.org\/10.1177\/2397198319863565 (2019).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.semarthrit.2011.07.006","volume":"41","author":"ML Iorio","year":"2012","unstructured":"Iorio, M. L., Masden, D. L. & Higgins, J. P. Botulinum toxin A treatment of Raynaud\u2019s phenomenon: a review. Semin. Arthritis Rheum. 41, 599\u2013603 (2012).","journal-title":"Semin. Arthritis Rheum."},{"key":"386_CR131","doi-asserted-by":"crossref","first-page":"864","DOI":"10.5114\/aoms.2015.48152","volume":"12","author":"P \u017bebryk","year":"2016","unstructured":"\u017bebryk, P. & Puszczewicz, M. J. Botulinum toxin A in the treatment of Raynaud\u2019s phenomenon: a systematic review. Arch. Med. Sci. 12, 864\u2013870 (2016).","journal-title":"Arch. Med. Sci."},{"key":"386_CR132","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.40123","volume":"69","author":"RJ Bello","year":"2017","unstructured":"Bello, R. J. et al. The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud\u2019s phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 69, 1661\u20131669 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"386_CR133","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0034-1376970","volume":"46","author":"MD Bene","year":"2014","unstructured":"Bene, M. D. et al. Autologous fat grafting for scleroderma-induced digital ulcers. An effective technique in patients with systemic sclerosis. Handchir. Mikrochir. Plast. Chir. 46, 242\u2013247 (2014).","journal-title":"Handchir. Mikrochir. Plast. Chir."},{"key":"386_CR134","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/PRS.0000000000000104","volume":"133","author":"J Bank","year":"2014","unstructured":"Bank, J., Fuller, S. M., Henry, G. I. & Zachary, L. S. Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality. Plast. Reconstr. Surg. 133, 1109\u20131118 (2014).","journal-title":"Plast. Reconstr. Surg."},{"key":"386_CR135","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/rheumatology\/ket432","volume":"53","author":"G Takagi","year":"2014","unstructured":"Takagi, G. et al. Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with systemic sclerosis: a pilot study. Rheumatology 53, 854\u2013859 (2014).","journal-title":"Rheumatology"},{"key":"386_CR136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-018-1792-8","volume":"21","author":"N Del Papa","year":"2019","unstructured":"Del Papa, N. et al. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study. Arthritis Res. Ther. 21, 7 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"386_CR137","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kev002","volume":"54","author":"M Hughes","year":"2015","unstructured":"Hughes, M. et al. Prediction and impact of attacks of Raynaud\u2019s phenomenon, as judged by patient perception. Rheumatology 54, 1443\u20131447 (2015).","journal-title":"Rheumatology"},{"key":"386_CR138","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/2397198318774307","volume":"3","author":"JD Pauling","year":"2018","unstructured":"Pauling, J. D. et al. Patient-reported outcome instruments for assessing Raynaud\u2019s phenomenon in systemic sclerosis: a SCTC Vascular Working Group report. J. Scleroderma Relat. Disord. 3, 249\u2013252 (2018).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"386_CR139","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/key026","volume":"58","author":"JD Pauling","year":"2019","unstructured":"Pauling, J. D., Saketkoo, L. A., Matucci-Cerinic, M., Ingegnoli, F. & Khanna, D. The patient experience of Raynaud\u2019s phenomenon in systemic sclerosis. Rheumatology 58, 18\u201326 (2019).","journal-title":"Rheumatology"},{"key":"386_CR140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.semarthrit.2018.08.001","volume":"48","author":"M Hughes","year":"2019","unstructured":"Hughes, M. & Pauling, J. D. Exploring the patient experience of digital ulcers in systemic sclerosis. Semin. Arthritis Rheum. 48, 888\u2013894 (2019).","journal-title":"Semin. Arthritis Rheum."},{"key":"386_CR141","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","volume":"70","author":"JD Pauling","year":"2018","unstructured":"Pauling, J. D. et al. Multinational qualitative research study exploring the patient experience of Raynaud\u2019s phenomenon in systemic sclerosis. Arthritis Care Res. 70, 1373\u20131384 (2018).","journal-title":"Arthritis Care Res."},{"key":"386_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24127","author":"M Hughes","year":"2019","unstructured":"Hughes, M. et al. A multi-centre qualitative study exploring the patient experience of digital ulcers in systemic sclerosis. Arthritis Care Res. https:\/\/doi.org\/10.1002\/acr.24127 (2019).","journal-title":"Arthritis Care Res."},{"key":"386_CR143","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.40242","volume":"69","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. et al. Efficacy and safety of selexipag in adults with Raynaud\u2019s phenomenon secondary to systemic sclerosis. Arthritis Rheumatol. 69, 2370\u20132379 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"386_CR144","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mvr.2015.06.009","volume":"101","author":"B Ruaro","year":"2015","unstructured":"Ruaro, B. et al. Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients. Microvasc. Res. 101, 82\u201385 (2015).","journal-title":"Microvasc. Res."},{"key":"386_CR145","first-page":"100","volume":"34","author":"A Murray","year":"2016","unstructured":"Murray, A. et al. Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography. Clin. Exp. Rheumatol. 34, 100\u2013105 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR146","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mvr.2016.12.008","volume":"111","author":"M Hughes","year":"2017","unstructured":"Hughes, M. et al. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate. Microvasc. Res. 111, 32\u201336 (2017).","journal-title":"Microvasc. Res."},{"key":"386_CR147","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/03009742.2016.1178802","volume":"46","author":"M Hughes","year":"2016","unstructured":"Hughes, M. et al. Digital ulcers in systemic sclerosis are associated with microangiopathic abnormalities of peri-lesional skin as assessed by capillaroscopy. Scand. J. Rheumatol. 46, 81\u201382 (2016).","journal-title":"Scand. J. Rheumatol."},{"key":"386_CR148","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/art.40377","volume":"70","author":"Y Allanore","year":"2018","unstructured":"Allanore, Y., Distler, O., Matucci-Cerinic, M. & Denton, C. P. Review: defining a unified vascular phenotype in systemic sclerosis. Arthritis Rheumatol. 70, 162\u2013170 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"386_CR149","first-page":"733","volume":"22","author":"M Beon","year":"2004","unstructured":"Beon, M., Harley, R., Wessels, A., Silver, R. & Ludwicka-Bradley, A. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis. Clin. Exp. Rheumatol. 22, 733\u2013742 (2004).","journal-title":"Clin. Exp. Rheumatol."},{"key":"386_CR150","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3899\/jrheum.180615","volume":"46","author":"AM van Roon","year":"2019","unstructured":"van Roon, A. M. et al. Abnormal nailfold capillaroscopy is common in patients with connective tissue disease and associated with abnormal pulmonary function tests. J. Rheumatol. 46, 1109\u20131116 (2019).","journal-title":"J. Rheumatol."},{"key":"386_CR151","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","volume":"75","author":"C Mihai","year":"2016","unstructured":"Mihai, C. et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann. Rheum. Dis. 75, 681\u2013686 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR152","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.2008.103382","volume":"69","author":"Y Allanore","year":"2010","unstructured":"Allanore, Y. et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research Group (EUSTAR) database of patients with systemic sclerosis. Ann. Rheum. Dis. 69, 218\u2013221 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR153","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/annrheumdis-2018-214161","volume":"78","author":"M Hughes","year":"2018","unstructured":"Hughes, M., Baker, A., Farrington, S. & Pauling, J. D. Patient organisation-led initiatives can play an important role in raising awareness about Raynaud\u2019s phenomenon and encourage earlier healthcare utilisation for high-risk groups. Ann. Rheum. Dis. 78, 439\u2013441 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"386_CR154","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3899\/jrheum.190463","volume":"46","author":"M Hughes","year":"2019","unstructured":"Hughes, M. Effect of season on internet searches for information on Raynaud phenomenon. J. Rheumatol. 46, 1543\u20131544 (2019).","journal-title":"J. Rheumatol."},{"key":"386_CR155","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3899\/jrheum.091117","volume":"37","author":"B Chikura","year":"2010","unstructured":"Chikura, B., Moore, T., Manning, J., Vail, A. & Herrick, A. L. Thumb involvement in Raynaud\u2019s phenomenon as an indicator of underlying connective tissue disease. J. Rheumatol. 37, 783\u2013786 (2010).","journal-title":"J. Rheumatol."}],"updated-by":[{"DOI":"10.1038\/s41584-021-00591-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000}}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0386-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-020-0386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T12:14:01Z","timestamp":1695816841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0386-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,15]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-0386-4","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"29 January 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41584-021-00591-5","URL":"https:\/\/doi.org\/10.1038\/s41584-021-00591-5","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.H. declares he has received speaker honoraria from Actelion. Y.A. declares he has or has had a consultancy relationship and\/or has received grants from Actelion, Bayer, BMS, Boehringer-Ingelheim, Inventiva, Roche, Sanofi-Aventis and Servier in the area of systemic sclerosis. L.C. declares she has consultancy or advisory relationships with BMS, Boehringer-Ingelheim, Eicos, Mitsubishi Tanabe and Reata. J.D.P. declares he has received speaker honoraria and research grant support from Actelion and has undertaken consultancy work for Actelion and Boehringer-Ingelheim. C.P.D. declares he has received research grants from CSL Behring, GlaxoSmithKline and Inventiva and consulting fees from Actelion, Bayer, Boehringer-Ingelheim, CSL Behring, Galapagos, GlaxoSmithKline, Inventiva, Leadiant, Roche and Sanofi. M.M.-C. declares he has received speaker honoraria from Actelion and Biogen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}